NAFDAC blacklists Onifam Laboratories over regulatory violations
Represented by the agency’s Director of Investigation and Enforcement, Martins Iluyomade, Ms Adeyeye said investigations revealed that the company engaged in regulatory misrepresentation, including the improper use of approvals and certificates, as well as activities that undermined product traceability, accountability and the integrity of the country’s medicines regulatory system.
Ms Adeyeye, who reiterated the agency’s commitment to safeguard the health of the nation, said NAFDAC would continue to preserve the integrity of Nigeria’s pharmaceutical regulatory system.
The agency’s boss noted that further investigation uncovered circumvention of regulatory controls through the importation, distribution, marketing, or sponsorship of regulated products, contrary to approved NAFDAC regulatory processes.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
